Answers are grounded in this paper and cite their sources.
Middle East respiratory syndrome coronavirus (MERS-CoV) with potential to cause global pandemics remains a threat to the public health, security, and economy. In this review, we focus on advances in the research and development of small-molecule MERS-CoV inhibitors targeting different stages of the MERS-CoV life cycle, aiming to prevent or treat MERS-CoV infection.
No takes yet. Share an insight, caveat, or question.
Liang et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: